截至15:00，恒生港股通创新药指数上涨1.0%，成份股中，云顶新耀涨超8%，复星医药涨超4%，三生制药涨超3%。截至上周五，恒生创新药ETF（159316）连续3个交易日获资金净流入，规模突破4亿元，再次创下成立以来新高。 太平洋证券表示，建议重视医药板块受市场定价权资金变化所带来的增量影响，尤其是阶段性布局AI医疗及创新药的投资策略，目前创新药流动性和风险偏好提升，数据和BD催化有望成为全年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.